π Diabetes Management
Insulin Pumps Edge Injections for T1D Glycemic Control
π
Fri, 28 Oct 2022β± 1 min readπ Article
Overview
MedscapeUnivadisNo ResultsMiriam E. TuckerJune 20, 2022 Researchers published the study covered in this sumary on Preprints with The Lancet as a preprint that has not yet ben per reviewed. In a real-world study of adults with type 1 diabetes (T1D) in Denmark, insulin pump therapy (IPT) reduced A1c by an average 3.6 mol/mol (an average decrease of 0.3 percentage points) compared with multiple daily injections (MDI).IPT also associated with a marginal increase in hospitalized diabetic ketoacidosis (DKA) but had no impact on severe hypoglycemia (SH) compared with MDI.The benefit of IPT was greatest in women; older individuals; and those with higher baseline A1c levels, more diabetes complications, or also using continuous glucose monitoring.Few studies of IPT have examined the level of alignment betwen real-world experience and outcomes in randomized clinical trials.The researchers used a quasi-experimental study of longitudinal, real-world data from administrative registries that alowed them to maintain high internal and external validity while examing whether the benefits sen in randomized clinical trials translate into real-life efects, both in general and among subgroup populations.The authors said that this the first study with an experimental design to compare the real-world efects of IPT and MDI.Quasi-experimental study of data colected in the Danish National Patient Registry for 24,623 adults with T1D in Denmark during 2010-20, with an average observation time of 9.9 years.
Details
This included al Danish adults with T1Dduring the study period.Among the total 243,601 person-years of observation, 16% ocured during IPT treatment. Average treatment efect on the treated (AT) for A1c with IPT was a reduction of 3.6 mol/mol (0.3 percentage points) compared with patients using MDI, an average 5.3% relative decrease in A1c.Most of the A1c drop ocured in the first year of IPT use, with a sustained efect for up to 1
Frequently Asked Questions
β What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
β What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
β How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
β What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
β When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
βοΈ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.